NCT05535166 Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma Status RECRUITING Phase PHASE2
NCT05527470 Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma Status RECRUITING Phase PHASE3
NCT05524168 SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05522894 AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC Status UNKNOWN Phase PHASE2
NCT05521997 Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT05516589 Neoadjuvant Chemotherapy, Tislelizumab With Afatinib for HNSCC Status COMPLETED Phase PHASE2
NCT05514912 Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial Status WITHDRAWN Phase PHASE2
NCT05502237 Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05498220 Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma Status TERMINATED Phase PHASE2
NCT05494190 The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma Status RECRUITING Phase NA
NCT05493501 Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE3
NCT05491512 A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer Status RECRUITING Phase PHASE2
NCT05489848 Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutation Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT05489211 Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Status RECRUITING Phase PHASE2
NCT05487391 A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection. Status RECRUITING Phase PHASE3
NCT05451043 Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED) Status RECRUITING Phase PHASE2
NCT05433597 A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC Status NOT_YET_RECRUITING Phase PHASE2/PHASE3
NCT05415709 Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT05410197 Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN) Status UNKNOWN Phase PHASE2
NCT05410145 A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation Status RECRUITING Phase PHASE1/PHASE2